Skip to search
Skip to main content
Skip to first result
Maxine Singer - Profiles in Science
Contact
About
Maxine Singer
The Maxine Singer Papers
Home
The Story
Biographical Overview
Nucleic Acids, the Genetic Code, and Transposable Genetic Elements: A Life in Research
Risk, Regulation, and Scientific Citizenship: The Controversy over Recombinant DNA Research
The Science Administrator as Advocate
Additional Resources
Glossary
Collection Items
search for
Search
Search
Home
Search results
Search
Search Constraints
Start Over
You searched for:
Subject
DNA, Recombinant
✖
Remove constraint Subject: DNA, Recombinant
1
-
66
of
66
Sort
by Date (newest to oldest)
Relevance
Title (A-Z)
Title (Z-A)
Date (oldest to newest)
Date (newest to oldest)
Number of results to display per page
100
per page
per page
10
per page
20
per page
50
per page
100
per page
View results as:
List
List
Gallery
Gallery
Masonry
Masonry
Slideshow
Slideshow
Search Results
×
The Scientific Committee on Genetic Experimentation (COGENE)
1 of 66
Letter from Maxine Singer to William J. Gartland
2 of 66
Letter from Maxine Singer to London Ganning
3 of 66
Letter from London Ganning to Maxine Singer
4 of 66
Interview with Dr. Maxine F. Singer [on recombinant DNA research and NIH]
5 of 66
Letter from Paul Berg to U.S. Senator Harrison Schmitt
6 of 66
Letter from Maxine Singer to Carolyn E. Kemp
7 of 66
Letter from Carolyn E. Kemp to Maxine Singer
8 of 66
Letter from Stanley N. Cohen to Maxine Singer
9 of 66
Letter from Roy Curtiss III to Donald S. Fredrickson
10 of 66
Minutes of the Eleventh Meeting of the Executive Recombinant DNA Committee
11 of 66
Memorandum from Maxine Singer to Donald S. Fredrickson
12 of 66
Ordinance No. 5010: Regulating the Use of Hazardous Biological Research in the City of Berkeley
13 of 66
Letter from Maxine Singer to Donald S. Fredrickson
14 of 66
Letter from Joshua Lederberg to U.S. Senators Alan Cranston and Samuel Ichiye Hayakawa
15 of 66
Letter from Maxine Singer to Lorill Brown-Rezanka
16 of 66
Letter from Roy Curtiss III to Maxine Singer
17 of 66
Letter from Roy Curtiss III to Donald S. Fredrickson
18 of 66
Memorandum from Michael Adler [summarizing the first day of hearings of the Thornton House Subcommittee on Science, Research, and Technology]
19 of 66
Testimony by David Baltimore for the Committee on Science and Technology
20 of 66
Letter from U.S. Representative Paul G. Rogers to Maxine Singer
21 of 66
Letter from Maxine Singer to Milton P. Gordon
22 of 66
Protestors and their banner at the March 1977 National Academy of Sciences Forum on Recombinant DNA
23 of 66
Robert Sinsheimer speaking at the March 1977 National Academy of Sciences Forum on Recombinant DNA
24 of 66
Roy Curtiss III speaking at the March 1977 National Academy of Sciences Forum on Recombinant DNA
25 of 66
Speaker from the audience at the March 1977 National Academy of Sciences Forum on Recombinant DNA
26 of 66
Paul Berg speaking at the March 1977 National Academy of Sciences Forum on Recombinant DNA
27 of 66
A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research
28 of 66
Ordinance for the Use of Recombinant Molecule Technology in the City of Cambridge
29 of 66
Testimony of Maxine Singer before the California State Legislature
30 of 66
Letter from Maxine Singer to U.S. Representative Richard Ottinger
31 of 66
Letter from David S. Hogness to DeWitt Stetten, Jr
32 of 66
Letter from Maxine Singer to Robert L. Sinsheimer
33 of 66
Letter from Maxine Singer to Charles Warren
34 of 66
Letter from Paul Berg to Robert L. Sinsheimer
35 of 66
Letter from Charles Warren and Barry Keene to Maxine Singer
36 of 66
A Statement
37 of 66
Letter from Maxine Singer to Wallace P. Rowe
38 of 66
Letter from Wallace P. Rowe to Maxine Singer
39 of 66
Roy Hudson listening in at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
40 of 66
David Hogness speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
41 of 66
Wallace Rowe speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
42 of 66
Susan Wright speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
43 of 66
Maxine Singer speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
44 of 66
David Baltimore speaking at the February 1976 NIH Director's Advisory Committee Meeting on Recombinant DNA
45 of 66
Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
46 of 66
Letter from David Baltimore to Fred C. Ikle
47 of 66
Letter from Maxine Singer to Willard Gaylin
48 of 66
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
49 of 66
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
50 of 66
Appendix F: Cloned Eukaryotic DNA
51 of 66
Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines
52 of 66
Report of the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
53 of 66
Memorandum from Maxine Singer to Paul Berg, David Baltimore, Sydney Brenner, and Richard O. Roblin on the latest draft of the Asilomar Reports
54 of 66
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
55 of 66
Memorandum from Paul Berg to the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
56 of 66
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
57 of 66
Appendix H: Provisional Statement of the Conference Proceedings
58 of 66
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
59 of 66
Appendix F: Cloned Eukaryotic DNA
60 of 66
Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms
61 of 66
Appendix C: Program of the International Conference on Recombinant DNA Molecules
62 of 66
Open Letter to the Asilomar Conference on Hazards of Recombinant DNA
63 of 66
Maxine Singer, Norton Zinder, Sydney Brenner, and Paul Berg at the 1975 Asilomar Conference
64 of 66
Memorandum from Allen Silverstone to the Advisory Committee on the Guidelines for Recombinant DNA
65 of 66
Potential Biohazards of Recombinant DNA Molecules [Letter to the Editor of Science]
66 of 66
previous image
next image
Pause Slideshow
Start Slideshow